Welcome to the latest edition of our Guidelines Rundown Series, where we shine a spotlight on the most recent bladder cancer guidelines in recognition of Bladder Health Awareness Month 2024. Multiple medical societies have recently published comprehensive guidelines aimed at assisting healthcare professionals in making informed clinical decisions regarding the diagnosis and treatment of bladder cancer, specifically non-muscle invasive bladder cancer and urothelial cancer.
Below, we present the clinical practice guidelines related to bladder cancer, which offer valuable insights for healthcare providers navigating the complexities of this disease.
Guidelines on Bladder Cancer
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer
- American Urological Association (AUA) and Society of Urologic Oncology (SUO)
- Publication: January 24, 2024
- Immunotherapy for the Treatment of Urothelial Cancer
- Society for Immunotherapy of Cancer (SITC)
- Publication: August 01, 2023
- Urothelial Cancer
- SITC
- Publication: May 23, 2021
- Immunotherapy for the Treatment of Bladder Cancer
- SITC
- Publication: August 15, 2017
- Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer
- American Society for Radiation Oncology (ASTRO), American Society of Clinical Oncology (ASCO), AUA, and SUO
- Publication: August 10, 2017
- Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer
- ASTRO, ASCO, AUA, and Society of Urodynamics Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
- Publication: April 26, 2017
Thank you for taking the time to review the latest bladder cancer guidelines. If there are any guidelines that we may have missed, please do not hesitate to bring them to our attention. Furthermore, we are open to suggestions for future topics to be covered in our Guidelines Rundown series. Don’t forget to sign up for alerts and stay informed on the latest published guidelines and articles. Stay tuned for our next installment!
Copyright © 2024 Guideline Central, All Rights Reserved.